Positive diabetes drug data triggers $20M payday for Zealand; Opsona names new CEO;

@FierceBiotech: Soligenix' proprietary vaccine thermostabilization technology passed through preclinical proof-of-concept studies. Release | Follow @FierceBiotech

@JohnCFierce: Celgene pays $15M for front-row seat on Acetylon myeloma program. Article | Follow @JohnCFierce

@FierceMedDev: EU wants more medical device controls after PIP scare. News via @Reuters | Follow @FierceMedDev

@MarkHFierce: A U.S. trial will test umbilical cord stem cells to treat /reverse hearing loss in babies. It worked in mice. More | Follow @MarkHFierce

> FDA rewards Roche with priority review for blockbuster cancer drug. News

> Copenhagen-based Zealand Pharma has earned a $20 million milestone with the successful completion of Sanofi's late-stage program for the diabetes drug lixisenatide. Release

> Alexion has closed on its deal to buy Enobia for $1.1 billion. Story

> Dr. Martin Welschof, previously managing director of Affitech, has taken the helm at Dublin-based Opsona Therapeutics as its new CEO. Conor Dalton, previously VP finance and chief accounting officer for Amarin, has joined Opsona as director of finance. Release

> Germany's Proteros biostructures announced that Dr. Klaus Hinterding, formerly at Roche, has joined the company as chief scientific officer. Release

Pharma News

@FiercePharma: Shire reports an enviable 47% spike in Q4 earnings, thanks to ADHD and rare-disease meds. Release | Follow @FiercePharma

> FDA panel nixes new use for Amgen's Xgeva. Article

> Watson chief has big brand plans for $6B war chest. Story

> Judge: No 1st Amendment shield for Astellas' Prograf petition. News

CRO News

> AZ's China R&D strategy calls for outsourcing. Item

> Takeda opens new drug development center in China. Article

> Quintiles report highlights the challenge of the 'value proposition.' Report

> AstraZeneca's latest restructuring spurs debate over outsourcing R&D. Story

> United Drug nails $40M pharma outsourcing contract. Piece

Vaccines News

> Merck's RotaTeq not linked with bowel problems. More

> Novartis' Bexsero successfully protects vast majority of infants. Article

> Researchers target vaccines for the First Nation. Story

> Hints of a heroin vaccine from Mexico. News

> Bacterial cancer vaccines show glimpses of activity. Piece

Manufacturing News

> Pakistan Supreme Court interjects itself in drug death scandal. News

> Being more like Coca-Cola takes days out of GSK's pharma supply chain. More

> Decision on new GSK plant location to come soon. Item

> ViroPharma responding quickly to FDA delay of Cinryze manufacturing expansion. Piece

And Finally... A group of epilepsy patients say electrical currents sent through their brains helped improve memory, suggesting that deep brain stimulation may help treat Alzheimer's and other ailments. Story